Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)

The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases through collaborative, multi-site, patient-centric research, with a strong emphasis on addressing unmet clinical trial readiness needs. The estimated total program funding is $1,000,000, and the FOA is expected to be published in 2024, with applications due later that year. For further inquiries, interested applicants can contact Dr. Tiina K. Urv at 301-827-2746 or via email at urvtiin@mail.nih.gov.